Yonna W. Y. Leung

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung et al. · Nature Medicine · 2022 · 371 citations · Full text

Vaccination, Heterologous Coronavac, Vaccine Development +7

SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease

Ranawaka A. P. M. Perera, Eugene Y. K. Tso, O. T. Y. Tsang et al. · Emerging infectious diseases · 2020 · 233 citations · Full text

Viral Diagnostics, Immunology, Viral Pathogenesis +16

Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines

Malik Peiris, Samuel M. S. Cheng, Chris Ka Pun Mok et al. · 2022 · 27 citations · Full text

SARS-CoV-2 virus culture from the upper respiratory tract: Correlation with viral load, subgenomic viral RNA and duration of illness.

Ranawaka A. P. M. Perera, Eugene Y. K. Tso, Owen TY Tsang et al. · 2020 · 19 citations · Full text

Upper Respiratory Tract, Viral Diagnostics, Viral Pathogenesis +20

Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine

Nancy Leung, Samuel M. S. Cheng, Mario Martín-Sánchez et al. · Clinical Infectious Diseases · 2022 · 18 citations · Full text